Cite
HARVARD Citation
Richter, A. et al. (2016). Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis. Annals of the rheumatic diseases. 75 (9), pp. 1667-1673. [Online].